GMP Manufacturing Live Microbial Products

GMP Manufacturing Live Microbial Products

Contract Manufacturing

Information

Wacker Biotech is a pioneer in new fields of Live Microbial Products, which are products containing whole, live microorganisms, such as bacteria or yeast with an intended therapeutic or preventive effect in humans (distributed oral, topical, intravenous etc.). Wacker Biotech has over 10 years of specialist experience in working with Live Microbial Products, which, involves, inter alia, the development of scalable and closed monoseptic production processes (aseptic handling from fermentation to filling of the product capable of parenteral administration). As a world leader in this field, we can offer both bulk drug substance and drug product production (including lyophilization) in our facilities in Amsterdam.
WackerWacker Biotech is “THE MICROBIAL CDMO” – the partner of choice for process transfer and/or development and commercial manufacturing of biopharmaceuticals (proteins, vaccines and live microbial products) using microbial hosts. Wacker Biotech has progressive experience producing vaccines, extending from classic inactivated and live attenuated vaccines to protein-based, polysaccharide and glycoconjugate vaccines. WACKER’s integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for (pre)clinical and commercial supply. WACKER’s outstanding E. coli technologies can significantly increase the bioprocess efficiency and thereby reduce the cost of goods. We produce with manufacturing lines with a capacity of up to 1,500L to flexibly serve our clients, ranging from small biotechnology companies to big pharmaceutical corporates.

Log in